Acute lymphocytic leukaemia
Not recruitingStudy on Obinutuzumab and Rituximab with Chemotherapy for Adults with Newly Diagnosed CD20-Positive Acute Lymphoblastic Leukemia
Study on Obinutuzumab and Rituximab with Chemotherapy for Adults with Newly Diagnosed CD20-Positive Acute Lymphoblastic Leukemia
- Disease:Acute lymphocytic leukaemia
- Substances:ObinutuzumabRituximab
Poland- Participants:18–64 years · 65+ years
- Substances:Obinutuzumab
- Sponsor:Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie-Panstwowy Instytut Badawczy









